Rhodanine as a Potent Scaffold for the Development of Broad Spectrum Metallo-beta-lactamase inhibitors
Rhodanine as a Potent Scaffold for the Development of Broad Spectrum Metallo-beta-lactamase inhibitors
复制标题
绕丹宁作为开发广谱金属-β-内酰胺酶抑制剂的有效支架
DOI:
10.1021/acsmedchemlett.7b00548
复制
发表时间:
2018
影响因子:
4.2
通讯作者:
He Yuan
中科院分区:
文献类型:
--
作者:
Xiang Yang;Chen Cheng;Wang Wen Ming;Xu Li Wei;Yang Ke Wu;Oelschlaeger Peter;He Yuan
A series of rhodanines was constructed, their Z-configuration was confirmed by small molecule X-ray crystal structures, and their activity against metallo-β-lactamases (MβLs) was measured. The obtained 26 molecules and a thioenolate specifically inhibited the MβL L1 with an IC50range of 0.02–1.7 μM, and compounds2h–mexhibited broad-spectrum inhibition of the MβLs NDM-1, VIM-2, ImiS, and L1 with IC50values <16 μM. All inhibitors increased the antimicrobial effect of cefazolin againstE. colicells expressing L1, resulting in a 2–8-fold reduction in MIC. Docking studies suggested that the nitro (NDM-1, CphA, and L1) or carboxyl group (VIM-2) of2lcoordinates one or two Zn(II) ions, while theN-phenyl group of the inhibitor enhances its hydrophobic interaction with MβLs. These studies demonstrate that the diaryl-substituted rhodanines are good scaffolds for the design of future broad-spectrum inhibitors of MβLs.